| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.085 | 0.6 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.086 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |